Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)Ramón García‐Sánz, Carmen Martı́nez, Anna Sureda et al.|Blood|2016Cited by 47
Under Scope of the Current Redefinition Process of Optimal Response in Multiple Myeloma: Assesment of Molecular Response by Fluorescent PCR of Ig Genes Has Similar Applicability and Prognosis Impact to Immunophenotypic Response. (A GEM/PETHEMA study),Elena Fernandez Redondo, Juan José Lahuerta, Pilar Martínez‐Sánchez et al.|Blood|2011Cited by 1